enVVeno Medical Corp Retained Earnings
enVVeno Medical Corp (NVNO) had Retained Earnings of -$178.78 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-30
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$178.78M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$175.18M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$171.33M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$167.59M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$178.78M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$175.18M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | -$171.33M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | -$167.59M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | -$163.05M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | -$156.36M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | -$151.85M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$145.63M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | -$139.98M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | -$135.03M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$130.04M 10-K · filed 2025-02-28 | |
| 2023-09-30 | -$124.39M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | -$119.39M 10-Q · filed 2023-07-31 | |
| 2023-03-31 | -$112.91M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | -$106.52M 10-K · filed 2024-02-29 | |
| 2022-09-30 | -$100.34M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | -$94.24M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | -$87.18M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | -$81.85M 10-K · filed 2023-03-02 | -$81.85M 10-K · filed 2022-03-28 |
| 2021-09-30 | -$72.86M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$70.47M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | -$68.10M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$65.32M 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$60.95M 10-Q · filed 2020-11-17 | |
| 2020-06-30 | -$58.97M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$57.35M 10-Q · filed 2020-06-08 | |
| 2019-12-31 | -$56.19M 10-K · filed 2021-03-31 | |
| 2019-09-30 | -$53.90M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | -$52.08M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | -$50.14M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$48.56M 10-K · filed 2020-03-18 | |
| 2018-09-30 | -$46.78M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | -$45.31M 10-Q · filed 2018-08-10 | |
| 2017-12-31 | -$35.52M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |